The reduction in expression of the E-cadherin and β-catenin markers in patients with malignant laryngeal neoplasm leads to a prognostic impact when related to the occurrence of cervical metastasis and greater local aggressiveness for E-cadherin in glottic tumors. This evidence concerns the gene CDH1 and larynx cancer.